135 related articles for article (PubMed ID: 30409919)
1. Modulation of Mutant
Zhou X; Padanad MS; Evers BM; Smith B; Novaresi N; Suresh S; Richardson JA; Stein E; Zhu J; Hammer RE; O'Donnell KA
Mol Cancer Res; 2019 Feb; 17(2):594-603. PubMed ID: 30409919
[TBL] [Abstract][Full Text] [Related]
2. FOSL1 Promotes Kras-induced Lung Cancer through Amphiregulin and Cell Survival Gene Regulation.
Elangovan IM; Vaz M; Tamatam CR; Potteti HR; Reddy NM; Reddy SP
Am J Respir Cell Mol Biol; 2018 May; 58(5):625-635. PubMed ID: 29112457
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth.
Tang R; Shuldiner EG; Kelly M; Murray CW; Hebert JD; Andrejka L; Tsai MK; Hughes NW; Parker MI; Cai H; Li YC; Wahl GM; Dunbrack RL; Jackson PK; Petrov DA; Winslow MM
Nat Cell Biol; 2023 Jan; 25(1):159-169. PubMed ID: 36635501
[TBL] [Abstract][Full Text] [Related]
4. Characterization of
Kim S; Kim J; Jung Y; Jun Y; Jung Y; Lee HY; Keum J; Park BJ; Lee J; Kim J; Lee S; Kim J
Mol Cells; 2020 Jul; 43(7):619-631. PubMed ID: 32638704
[TBL] [Abstract][Full Text] [Related]
5. Critical requirement of SOS1 for tumor development and microenvironment modulation in KRAS
Baltanás FC; García-Navas R; Rodríguez-Ramos P; Calzada N; Cuesta C; Borrajo J; Fuentes-Mateos R; Olarte-San Juan A; Vidaña N; Castellano E; Santos E
Nat Commun; 2023 Sep; 14(1):5856. PubMed ID: 37730692
[TBL] [Abstract][Full Text] [Related]
6. E-Cadherin Loss Accelerates Tumor Progression and Metastasis in a Mouse Model of Lung Adenocarcinoma.
Sinkevicius KW; Bellaria KJ; Barrios J; Pessina P; Gupta M; Brainson CF; Bronson RT; Kim CF
Am J Respir Cell Mol Biol; 2018 Aug; 59(2):237-245. PubMed ID: 29447458
[TBL] [Abstract][Full Text] [Related]
7. UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
Kostyrko K; Román M; Lee AG; Simpson DR; Dinh PT; Leung SG; Marini KD; Kelly MR; Broyde J; Califano A; Jackson PK; Sweet-Cordero EA
Nat Commun; 2023 Jul; 14(1):3966. PubMed ID: 37407562
[TBL] [Abstract][Full Text] [Related]
8. AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.
Tien JC; Chugh S; Goodrum AE; Cheng Y; Mannan R; Zhang Y; Wang L; Dommeti VL; Wang X; Xu A; Hon J; Kenum C; Su F; Wang R; Cao X; Shankar S; Chinnaiyan AM
Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33972443
[TBL] [Abstract][Full Text] [Related]
9. KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming.
Juul NH; Yoon JK; Martinez MC; Rishi N; Kazadaeva YI; Morri M; Neff NF; Trope WL; Shrager JB; Sinha R; Desai TJ
Nature; 2023 Jul; 619(7971):860-867. PubMed ID: 37468622
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.
Mustachio LM; Lu Y; Tafe LJ; Memoli V; Rodriguez-Canales J; Mino B; Villalobos PA; Wistuba I; Katayama H; Hanash SM; Roszik J; Kawakami M; Cho KJ; Hancock JF; Chinyengetere F; Hu S; Liu X; Freemantle SJ; Dmitrovsky E
Mol Cancer Res; 2017 Jul; 15(7):905-914. PubMed ID: 28242811
[No Abstract] [Full Text] [Related]
11. Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species.
Kasiri S; Chen B; Wilson AN; Reczek A; Mazambani S; Gadhvi J; Noel E; Marriam U; Mino B; Lu W; Girard L; Solis LM; Luby-Phelps K; Bishop J; Kim JW; Kim J
Oncogene; 2020 Apr; 39(16):3258-3275. PubMed ID: 32108165
[TBL] [Abstract][Full Text] [Related]
12. Sirt1 protects from K-Ras-driven lung carcinogenesis.
Costa-Machado LF; Martín-Hernández R; Sanchez-Luengo MÁ; Hess K; Vales-Villamarin C; Barradas M; Lynch C; de la Nava D; Diaz-Ruiz A; de Cabo R; Cañamero M; Martinez L; Sanchez-Carbayo M; Herranz D; Serrano M; Fernandez-Marcos PJ
EMBO Rep; 2018 Sep; 19(9):. PubMed ID: 30021836
[TBL] [Abstract][Full Text] [Related]
13. Targeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage.
Deng H; Gao Y; Trappetti V; Hertig D; Karatkevich D; Losmanova T; Urzi C; Ge H; Geest GA; Bruggmann R; Djonov V; Nuoffer JM; Vermathen P; Zamboni N; Riether C; Ochsenbein A; Peng RW; Kocher GJ; Schmid RA; Dorn P; Marti TM
Cell Mol Life Sci; 2022 Jul; 79(8):445. PubMed ID: 35877003
[TBL] [Abstract][Full Text] [Related]
14. Alveolar type I cells can give rise to KRAS-induced lung adenocarcinoma.
Yang M; Shen H; Flodby P; Koss MD; Bassiouni R; Liu Y; Jashashvili T; Neely A; Ogbolu E; Castillo J; Stueve TR; Mullen DJ; Ryan AL; Carpten J; Castaldi A; Wallace WD; Zhou B; Borok Z; Marconett CN
Cell Rep; 2023 Dec; 42(12):113286. PubMed ID: 37995179
[TBL] [Abstract][Full Text] [Related]
15. Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10.
Yang J; Hou C; Wang H; Perez EA; Do-Umehara HC; Dong H; Arunagiri V; Tong F; Van Scoyk M; Cho M; Liu X; Ge X; Winn RA; Ridge KM; Wang X; Chandel NS; Liu J
Cancer Lett; 2023 Feb; 555():216025. PubMed ID: 36538983
[TBL] [Abstract][Full Text] [Related]
16. SETD2 regulates chromatin accessibility and transcription to suppress lung tumorigenesis.
Xie Y; Sahin M; Wakamatsu T; Inoue-Yamauchi A; Zhao W; Han S; Nargund AM; Yang S; Lyu Y; Hsieh JJ; Leslie CS; Cheng EH
JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810256
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic KRAS and p53 Loss Drive Gastric Tumorigenesis in Mice That Can Be Attenuated by E-Cadherin Expression.
Till JE; Yoon C; Kim BJ; Roby K; Addai P; Jonokuchi E; Tang LH; Yoon SS; Ryeom S
Cancer Res; 2017 Oct; 77(19):5349-5359. PubMed ID: 28760854
[TBL] [Abstract][Full Text] [Related]
18. An optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1.
Deng H; Ge H; Dubey C; Losmanova T; Medová M; Konstantinidou G; Mutlu SM; Birrer FE; Brodie TM; Stroka D; Wang W; Peng RW; Dorn P; Marti TM
Cancer Immunol Immunother; 2023 Dec; 72(12):4457-4470. PubMed ID: 37796299
[TBL] [Abstract][Full Text] [Related]
19. HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma.
Li Y; Zhang X; Zhu S; Dejene EA; Peng W; Sepulveda A; Seto E
Cancer Res; 2020 Aug; 80(16):3265-3278. PubMed ID: 32540961
[TBL] [Abstract][Full Text] [Related]
20. Rapid modelling of cooperating genetic events in cancer through somatic genome editing.
Sánchez-Rivera FJ; Papagiannakopoulos T; Romero R; Tammela T; Bauer MR; Bhutkar A; Joshi NS; Subbaraj L; Bronson RT; Xue W; Jacks T
Nature; 2014 Dec; 516(7531):428-31. PubMed ID: 25337879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]